Total Funding
85
21
Total FundingFunding Round raised
Growth Score
-7 pts
Heat Score
-42 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
30055
Codetta Bio is a company developing quantitative & digital spatial platform for nucleic acid & protein assays.
- Jacques Corriveau: President and CEOPast Role: Ultivue, President & CEO
- Jay Gerlach: Vice President of MarketingPast Role: Sphere Bio, Vice President of Marketing
About the Company
Codetta Bio is a life sciences company working on a novel multi-omic analysis platform based on digital spatial polymerase chain reaction (dsPCR) and digital spatial immuno polymerase chain reaction (dsIPCR) (dsiPCR). Its integrated reagent, hardware, and software platform enable multiplexed, multi-omic liquid biopsy and isolated DNA, RNA, and
protein analyses. The company aims to provide the life sciences community with a simultaneous multi-omic dsPCR solution that will accelerate research and development of next-generation therapies, improving patient care and quality of life.
